Trial
NCT02319304
Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
Rectal Adenocarcinoma
Intervention
FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}
Why stopped
Slow accrual, PI left instituion
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-04